Skip to content

Endovascular Treatment for Infra-inguinal Vessel, in patients with critical limb ischemia, - A Prospective, Multi-center, 12 month follow-up Registry in Japan -

Endovascular Treatment for Infra-inguinal Vessel, in patients with critical limb ischemia, - A Prospective, Multi-center, 12 month follow-up Registry in Japan - - OLIVE Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000002830
Enrollment
300
Registered
2009-12-02
Start date
2009-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with peripheral artery disease (PAD) associated with critical limbs ischemia (CLI)

Interventions

None listed

Sponsors

OLIVE Registry Study Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a.Patients who can provide an informed consent and are aged 20 years or older when providing the consent b.CLI has been diagnosed, and revascularization with EVT is indicated. c.Revascularization in infra-popliteal arteries with EVT was conducted or was to be conducted. d.Follow-up for one year or longer is considered feasible.

Exclusion criteria

Exclusion criteria: << Exclusion criteria for patients >> e.Patients with any limb which has already undergone major amputation due to ischemic disease f.Patients with CLI in both limbs in which ischemic ulcer or gangrene is observed. g.Patients who are considered to have the life expectancy of one year or shorter. h.Patients in whom QOL evaluation is difficult due to dementia or the other reason. i.Patients who may not allow long-term follow-up << Exclusion criteria for the affected limb >> j.Affected limbs in which ischemic ulcer or gangrene widely spreads beyond the tarsometatarsal region k.Affected limbs which have undergone EVT in the lower limb arteries including the abdominal aorta and iliac artery and/or femoral artery in the affected limb for the last four weeks l.Affected limbs which are to undergo EVT as pre-treatment of the major lower limb amputation, or of which the major lower limb amputation is considered inevitable regardless of EVT practice. m.Affected limbs which have undergone EVT in the abdominal aorta or iliac artery concurrently with EVT in the infra-inguinal arteries

Design outcomes

Primary

MeasureTime frame
Rate free of major lower limb amputation at 12 months after the EVT. This means that a patient survives without undergoing major lower limb amputation.

Countries

Japan

Contacts

Public ContactOsamu Iida

Kansai Rosai Hospital division of cardiovascular disease

06-6416-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026